non-surgical procedures for abdomen contours after weight loss glp-1 Body Contouring NYC Sculpt your body. No surgery.

Current Development Status and Availability in the UK Retatrutide is currently in Phase 3 development and holds no marketing authorisation from the MHRA, EMA, or FDA

Key interactions (including with anticoagulants and antiepileptics) and contraindications are detailed in the relevant SmPCs (emc)

doi:10.1111/j.1463-1326.2012.01663.x 9

WHAT IS SEMAGLUTIDE

Most people report no dramatic changes during this introductory period

This was followed by a national patient safety alert in July 2023, which advised providers to proactively identify all patients established on treatment with GLP-1 RAs to discuss stopping treatment if they had not achieved targets set out in NICE guidance